SequelSEC

PRO DEX INC PDEX

Surgical & Medical Instruments & Apparatus · CIK 0000788920 · Fiscal year ends 0630

Revenue
$77.55M
Fiscal year ended 2026-06-30
Operating income
$12.99M
Fiscal year ended 2026-06-30
Free cash flow
$6.76M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$67.80MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-12-31
Float per share$21.17Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / net income5.0×A lower bound on the multiple, because affiliate holdings are excluded.
Float / revenue0.9×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity1.4×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-12-31, not today, and each multiple below it uses the figures for the fiscal year ending 2026-06-30 — the year that filing covered.

Valuation over time

5.0× earnings today, against a median of 8.1× across 10 years on record. Below its own history.

Float measuredPublic floatFloat / net income
2025-12-31$67.80M5.0×
2024-12-31$79.90M8.9×
2023-12-29$35.50M16.7×
2022-12-31$32.50M4.6×
2021-12-31$50.10M11.0×
2020-12-31$74.60M12.1×
2019-12-31$41.50M6.8×
2018-12-31$30.60M7.4×
2017-12-31$17.80M11.0×
2016-12-31$10.80M2.1×

Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
SBC / revenue0.9%6th
Net margin17.6%91th
Operating margin16.8%89th
CapEx / revenue0.6%12th
Gross margin31.4%15th
R&D / revenue4.3%21th
FCF margin8.7%77th
Effective tax rate24.2%71th
Current ratio4.10x62th
Revenue YoY growth16.5%59th

PRO DEX INC (PDEX) reported revenue of $77.55M and net income of $13.66M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from PRO DEX INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

PRO DEX INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Revenue$77.55M$66.59M$53.84M$46.09M$42.04M$38.03M$34.83M$27.17M$22.46M$21.94M
Cost of revenue$53.21M$47.08M$39.29M$33.34M$28.91M$24.45M$21.69M$17.39M$14.52M$14.76M
Gross profit$24.34M$19.51M$14.55M$12.75M$13.13M$13.58M$13.14M$9.78M$7.94M$7.19M
Operating income$12.99M$10.69M$7.17M$5.76M$5.12M$4.52M$7.07M$5.00M$2.39M$2.74M
Net income$13.66M$8.98M$2.13M$7.07M$4.57M$6.17M$6.11M$4.15M$1.62M$5.08M
Research & development$3.34M$3.64M$3.19M$2.80M$2.98M$4.38M$2.32M$1.88M$1.89M$1.22M
Weighted-average diluted sharesshares 3.32Mshares 3.36Mshares 3.57Mshares 3.64Mshares 3.76Mshares 3.94Mshares 4.08Mshares 4.30Mshares 4.34Mshares 4.08M
Pretax income$18.02M$12.06M$2.63M$9.43M$5.69M$7.62M$7.90M$5.45M$2.61M$2.75M
Income tax expense$4.35M$3.08M$507.00K$2.35M$1.12M$1.45M$1.79M$1.30M$989.00K-$2.09M
Diluted EPS$4.12$2.67$0.60$1.95$1.21$1.57$1.50$0.97$0.37$1.25
Selling, general & administrative$8.00M$5.18MUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrativeUnavailable$4.84M$4.07M$4.03M$4.90M$4.08M$3.19M$2.49M$2.29M$2.53M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

PRO DEX INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Cash & equivalents$8.19M$419.00K$2.63M$2.94M$849.00K$3.72M$6.42M$7.74M$5.19M$4.20M
Total assets$74.51M$61.19M$52.48M$51.82M$49.09M$40.32M$31.13M$25.52M$19.92M$16.35M
Current assets$53.25M$47.30M$36.61M$30.98M$31.17M$25.01M$22.67M$20.84M$16.23M$12.28M
Total liabilities$26.88M$24.56M$21.61M$20.23M$23.66M$20.24M$12.06M$8.51M$2.64M$2.64M
Current liabilities$12.98M$14.63M$12.89M$9.68M$11.35M$6.27M$5.23M$4.27M$2.42M$2.58M
Total equity incl. NCI$47.63M$36.63M$30.87M$31.59M$25.43M$21.13M$19.06M$17.01M$17.28M$13.71M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$21.46M$22.21M$15.27M$16.17M$12.68M$8.44M$8.24M$6.24M$4.39M$3.08M
Accounts receivable$21.20M$16.43M$13.89M$9.95M$15.38M$10.93M$5.16M$4.10M$2.96M$3.54M
Goodwill$6.52MUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$112.00K
Long-term debt$17.51M$15.43M$11.96M$12.80M$13.59M$11.54M$3.28M$3.93M$6.00K$61.00K
Accounts payable$4.26M$4.61M$4.51M$2.26M$3.76M$2.29M$1.96M$2.00M$1.08M$1.16M

Cash flow

PRO DEX INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Operating cash flow$7.24M-$1.68M$6.22M$5.46M-$847.00K-$2.08M$4.94M$3.33M$3.10M$3.24M
Capital expenditures$483.00K$1.25MUnavailableUnavailable$1.64M$1.77M$519.00K$1.39MUnavailableUnavailable
Investing cash flow$3.91M-$238.00K-$2.23M-$885.00K-$1.24M-$3.71M-$2.29M-$1.22M-$4.12M-$1.03M
Financing cash flow-$3.38M-$292.00K-$4.30M-$2.49M-$790.00K$3.09M-$3.98M$450.00K$2.00M-$298.00K
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$2.55M$983.00K$1.91M
Stock-based compensation$688.00K$555.00K$605.00K$766.00K$1.28M$901.00K$286.00K$37.00K$194.00K$3.00K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchases$3.41M$3.50M$3.50M$1.55M$1.61M$5.54M$3.39M$3.98M$220.00K$312.00K
Depreciation & amortization$1.39M$1.24M$1.16M$857.00K$726.00K$686.00K$573.00K$438.00K$557.00K$555.00K

Derived

PRO DEX INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Free cash flow$6.76M-$2.93MUnavailableUnavailableUnavailableUnavailable$4.43M$1.94MUnavailableUnavailable
Gross margin31.4%29.3%27.0%27.7%31.2%35.7%37.7%36.0%35.4%32.7%
Operating margin16.8%16.1%13.3%12.5%12.2%11.9%20.3%18.4%10.6%12.5%
FCF margin8.7%-4.4%UnavailableUnavailableUnavailableUnavailable12.7%7.1%UnavailableUnavailable
SBC / revenue0.9%0.8%1.1%1.7%3.0%2.4%0.8%0.1%0.9%0.0%
Current ratio4.10x3.23x2.84x3.20x2.74x3.99x4.34x4.88x6.72x4.76x
Revenue YoY growth16.5%23.7%16.8%9.6%10.5%9.2%28.2%21.0%2.4%Unavailable
Net margin17.6%13.5%4.0%15.3%10.9%16.2%17.5%15.3%7.2%23.2%
R&D / revenue4.3%5.5%5.9%6.1%7.1%11.5%6.6%6.9%8.4%5.6%
CapEx / revenue0.6%1.9%UnavailableUnavailableUnavailableUnavailable1.5%5.1%UnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate24.2%25.5%19.2%25.0%19.7%19.0%22.7%23.8%37.9%-75.9%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PDEX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-10-29View SEC filing
10-K · Filed 2026-09-03View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-Q · Filed 2026-01-29View SEC filing
10-Q · Filed 2025-10-30View SEC filing
10-K · Filed 2025-09-04View SEC filing

Companies in the same industry

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2021-06-30

Difference 1046000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.